Phase II study of OXE-103 for treatment of concussion
Phase of Trial: Phase II
Latest Information Update: 19 Aug 2017
At a glance
- Drugs OXE 103 (Primary)
- Indications Concussion
- Focus Therapeutic Use
- 19 Aug 2017 There could be multiple trials in consussion and other neurological indications. I have created one please update when more information is available.
- 07 Aug 2017 New trial record
- 02 Aug 2017 According to an Oxeia Biopharmaceuticals media release, the company anticipates initiation of this study in early 2018.